Revealing Drug Self-Associations into Nano-Entities
Author(s) -
Marwa Dlim,
Fatma Shahout,
Marwa K. Khabir,
Patrick Labonté,
Steven R. LaPlante
Publication year - 2019
Publication title -
acs omega
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.779
H-Index - 40
ISSN - 2470-1343
DOI - 10.1021/acsomega.9b00667
Subject(s) - fulvestrant , nano , lapatinib , nanotechnology , drug , gefitinib , materials science , chemistry , pharmacology , cancer , medicine , breast cancer , epidermal growth factor receptor , trastuzumab , tamoxifen , composite material
The aqueous properties of the drugs Sorafenib, Lapatinib, Gefitinib, Fulvestrant, and Clofazimine were explored to monitor their tendency to self-associate. A combination of nuclear magnetic resonance, dynamics light scattering, and electron and confocal microscopies found that they tended to form large nano-entities having distinct types and sizes and were capable of entering cells. The combination of strategies employed serves to detect and reveal nano-entities along with their three-state equilibria and behaviors in buffers, media, and cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom